LEP and Insulin resistance: Impaired activation of GIPR and GLP-1R contributes to a decrease in the secretion of insulin and ghrelin and, on the contrary, to an increase in leptin and glucagon in the circulation, which contributes to the formation of insulin resistance in obese patients with T2DM.